1. United States of America Stocks

  2. •

    Healthcare

  3. •

    Biotechnology
PMV Pharmaceuticals, Inc.

PMV Pharmaceuticals, Inc.

PMVP
PMV Pharmaceuticals, Inc.US flagNASDAQ Global Select
1.31
USD
+0.03
- -
69.86MMarket Cap

Income Statement (USD)

APIChatGPT
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
As of date
12/31/2018
12/31/2019
12/31/2020
12/31/2021
12/31/2022
12/31/2023
12/31/2024
12/31/2025
Sales/Revenue/Turnover
- -
- -
- -
- -
- -
- -
- -
- -
+ Sales & Services Revenue
- -
- -
- -
- -
- -
- -
- -
- -
- Cost of Revenue
- -
- -
- -
- -
- -
- -
- -
- -
+ Cost of Goods & Services
- -
- -
- -
- -
- -
- -
- -
- -
Gross Profit
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Operating Income
- -
- -
- -
- -
- -
- -
- -
- -
- Operating Expenses
19
27
35
58
77
80
85
86
+ Selling, General & Admin
5
6
11
22
25
24
27
16
+ Research & Development
14
21
24
36
52
56
59
70
+ Other Operating Expense
- -
- -
- -
- -
- -
- -
- -
- -
Operating Income (Loss)
-19
-27
-35
-58
-77
-80
-85
-86
- Non-Operating (Income) Loss
-1
-1
-1
- -
-4
-11
-11
-6
+ Interest Expense, Net
-1
-1
-1
- -
-4
-11
-11
-6
+ Interest Expense
- -
- -
- -
- -
- -
- -
- -
- -
- Interest Income
1
1
1
- -
4
11
11
6
+ Other Non-Op (Income) Loss
- -
- -
- -
- -
- -
- -
- -
- -
Pretax Income
-18
-25
-34
-58
-73
-69
-75
-80
- Income Tax Expense (Benefit)
- -
- -
- -
- -
- -
- -
-16
-2
- (Income) Loss from Affiliates
- -
- -
- -
- -
- -
- -
- -
- -
Income (Loss) from Cont Ops
-18
-25
-34
-58
-73
-69
-59
-78
- Net Extraordinary Losses (Gains)
- -
- -
- -
- -
- -
- -
- -
- -
+ Discontinued Operations
- -
- -
- -
- -
- -
- -
- -
- -
+ Extraord. & Accounting Changes
- -
- -
- -
- -
- -
- -
- -
- -
Income (Loss) Incl. MI
-18
-25
-34
-58
-73
-69
-59
-78
- Minority Interest
- -
- -
- -
- -
- -
- -
- -
- -
Net Income, GAAP
-18
-25
-34
-58
-73
-69
-59
-78
- Preferred Dividends
- -
- -
- -
- -
- -
- -
- -
- -
- Other Adjustments
- -
- -
- -
- -
- -
- -
- -
- -
Net Income Avail to Common, GAAP
-18
-25
-34
-58
-73
-69
-59
-78
EBIT
-19
-27
-35
-58
-77
-80
-85
-86
EBITDA
-19
-26
-35
-58
-77
-79
-84
-86
EBITDA Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
EBITA
-19
-27
-35
-58
-77
-80
-85
-86
Gross Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
Operating Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
Profit Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
Sales per Employee
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
Depreciation Expense
- -
- -
- -
- -
- -
1
1
- -
Basic Weighted Avg Shares
31
31
14
45
46
48
52
53
Basic EPS, GAAP
-0.56
-0.81
-2.4
-1.28
-1.61
-1.44
-1.14
-1.48
Basic EPS from Cont Ops
-0.56
-0.81
-2.4
-1.28
-1.61
-1.44
-1.14
-1.48
Diluted Weighted Avg Shares
31
31
14
45
46
48
52
53
Diluted EPS, GAAP
-0.56
-0.81
-2.4
-1.28
-1.61
-1.44
-1.14
-1.48
Diluted EPS from Cont Ops
-0.56
-0.81
-2.4
-1.28
-1.61
-1.44
-1.14
-1.48

Balance Sheet (USD)

APIChatGPT
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
As of date
12/31/2018
12/31/2019
12/31/2020
12/31/2021
12/31/2022
12/31/2023
12/31/2024
12/31/2025
Total Current Assets
62
102
365
301
247
207
176
115
+ Cash, Cash Equivalents & STI
62
101
361
297
241
203
169
113
+ Cash & Cash Equivalents
30
73
361
172
108
38
41
38
+ ST Investments
32
28
- -
125
133
165
129
75
+ Accounts & Notes Receiv
- -
- -
- -
- -
- -
- -
- -
- -
+ Accounts Receivable, Net
- -
- -
- -
- -
- -
- -
- -
- -
+ Notes Receivable, Net
- -
- -
- -
- -
- -
- -
- -
- -
+ Loans Receivable, Net
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Receivable, Net
- -
- -
- -
- -
- -
- -
- -
- -
+ Inventories
- -
- -
- -
- -
- -
- -
- -
- -
+ Raw Materials
- -
- -
- -
- -
- -
- -
- -
- -
+ Work In Process
- -
- -
- -
- -
- -
- -
- -
- -
+ Finished Goods
- -
- -
- -
- -
- -
- -
- -
- -
+ Inventory Adjustments
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Inventory
- -
- -
- -
- -
- -
- -
- -
- -
+ Other ST Assets
- -
1
3
4
6
4
6
2
+ Misc ST Assets
- -
- -
- -
- -
- -
- -
- -
- -
+ Prepaid Expenses
- -
- -
- -
- -
- -
- -
- -
- -
+ ST Derivative & Hedging Assets
- -
- -
- -
- -
- -
- -
- -
- -
+ ST Assets Held-for-Sale
- -
- -
- -
- -
- -
- -
- -
- -
+ ST Deferred Tax Assets
- -
- -
- -
- -
- -
- -
- -
- -
Total Noncurrent Assets
1
1
1
30
23
45
16
1
+ Property, Plant & Equip, Net
1
1
1
13
20
19
2
1
+ Property, Plant & Equip
2
2
2
15
23
22
3
2
- Accumulated Depreciation
1
1
2
2
2
3
1
1
+ LT Investments & Receivables
- -
- -
- -
17
2
26
14
- -
+ LT Investments
- -
- -
- -
17
2
26
14
- -
+ LT Receivables
- -
- -
- -
- -
- -
- -
- -
- -
+ Other LT Assets
- -
- -
- -
- -
- -
- -
- -
- -
+ Total Intangible Assets
- -
- -
- -
- -
- -
- -
- -
- -
+ Goodwill
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Intangible Assets
- -
- -
- -
- -
- -
- -
- -
- -
+ LT Deferred Tax Assets
- -
- -
- -
- -
- -
- -
- -
- -
+ LT Derivative & Hedging Assets
- -
- -
- -
- -
- -
- -
- -
- -
+ Misc LT Assets
- -
- -
- -
- -
- -
- -
- -
- -
Total Assets
63
103
366
332
270
252
191
117
+ Payables & Accruals
1
3
3
8
7
9
9
6
+ Accounts Payable
1
3
2
3
3
3
7
3
+ Accrued Taxes
- -
- -
- -
- -
- -
- -
- -
- -
+ Interest & Dividends Payable
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Payables & Accruals
- -
- -
2
5
4
5
2
3
+ ST Debt
- -
- -
- -
- -
1
1
- -
- -
+ ST Borrowings
- -
- -
- -
- -
- -
- -
- -
- -
+ ST Finance Leases
- -
- -
- -
- -
1
1
- -
- -
+ Other ST Liabilities
1
2
3
4
3
4
5
5
+ Deferred Revenue
- -
- -
- -
- -
- -
- -
- -
- -
+ Derivatives & Hedging
- -
- -
- -
- -
- -
- -
- -
- -
+ Deferred Tax Liabilities
- -
- -
- -
- -
- -
- -
- -
- -
+ Misc ST Liabilities
1
2
3
4
3
4
5
5
Total Current Liabilities
2
5
6
12
11
14
14
11
+ LT Debt
- -
- -
- -
11
13
12
1
- -
+ LT Borrowings
- -
- -
- -
- -
- -
- -
- -
- -
+ LT Finance Leases
- -
- -
- -
11
13
12
1
- -
+ Other LT Liabilities
107
169
- -
- -
- -
- -
- -
- -
+ Accrued Liabilities
- -
- -
- -
- -
- -
- -
- -
- -
+ Pension Liabilities
- -
- -
- -
- -
- -
- -
- -
- -
+ Deferred Revenue
- -
- -
- -
- -
- -
- -
- -
- -
+ Deferred Tax Liabilities
- -
- -
- -
- -
- -
- -
- -
- -
+ Derivatives & Hedging
- -
- -
- -
- -
- -
- -
- -
- -
+ Misc LT Liabilities
107
169
- -
- -
- -
- -
- -
- -
Total Noncurrent Liabilities
107
169
- -
11
13
12
1
- -
Total Liabilities
110
174
6
23
24
26
15
12
+ Preferred Equity and Hybrid Capital
- -
- -
- -
- -
- -
- -
- -
- -
+ Share Capital & APIC
4
5
469
476
488
535
545
551
+ Common Stock
- -
- -
- -
- -
- -
- -
- -
- -
+ Additional Paid in Capital
4
5
469
476
488
535
545
551
- Treasury Stock
- -
- -
- -
- -
- -
- -
- -
- -
+ Retained Earnings
-50
-75
-110
-168
-241
-310
-369
-446
+ Other Equity
- -
- -
- -
- -
- -
- -
- -
- -
Equity Before Minority Interest
-46
-70
359
309
246
226
176
105
+ Minority/Non Controlling Interest
- -
- -
- -
- -
- -
- -
- -
- -
Total Equity
-46
-70
359
309
246
226
176
105
Total Liabilities & Equity
63
103
366
332
270
252
191
117
Shares Outstanding
43
45
45
45
46
51
52
53
Number of Employees
- -
- -
- -
- -
- -
- -
- -
- -
Capital Leases - Total
- -
- -
- -
11
14
13
1
1
Net Debt
-30
-73
-361
-172
-108
-38
-41
-38
Net Debt to Equity
65.68
103.98
-100.64
-55.89
-44.02
-16.71
-23.21
-36.27
Tangible Common Equity Ratio
-72.71
-68.4
98.25
93.06
91.02
89.51
92.05
89.83
Current Ratio
26.75
22.57
56.9
24.66
22.8
14.78
12.22
10.09
Cash Conversion Cycle
- -
- -
- -
- -
- -
- -
- -
- -

Cash Flow Statement (USD)

APIChatGPT
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
As of date
12/31/2018
12/31/2019
12/31/2020
12/31/2021
12/31/2022
12/31/2023
12/31/2024
12/31/2025
+ Net Income
-18
-25
-34
-58
-73
-69
-59
-78
+ Depreciation & Amortization
- -
- -
- -
- -
- -
1
1
- -
+ Non-Cash Items
1
1
2
7
10
7
8
3
+ Stock-Based Compensation
1
1
2
5
10
12
9
6
+ Deferred Income Taxes
- -
- -
- -
- -
- -
- -
- -
- -
+ Asset Impairment Charge
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Non-Cash Adj
- -
- -
- -
2
- -
-6
-1
-3
+ Chg in Non-Cash Work Cap
1
2
-1
4
-1
5
-2
1
+ (Inc) Dec in Accts Receiv
- -
- -
- -
- -
- -
- -
- -
- -
+ (Inc) Dec in Inventories
- -
- -
- -
- -
- -
- -
- -
- -
+ (Inc) Dec in Prepaid Assets
- -
- -
-3
- -
-2
2
-3
4
+ Inc (Dec) in Accts Payable
1
2
2
4
-2
3
1
-3
+ Inc (Dec) in Other
- -
- -
- -
- -
3
1
- -
- -
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
- -
- -
Cash from Operating Activities
-15
-22
-33
-47
-64
-56
-51
-74
+ Change in Fixed & Intang
- -
- -
- -
- -
- -
- -
- -
- -
+ Disp in Fixed & Intang
- -
- -
- -
- -
- -
- -
- -
- -
+ Disp of Fixed Prod Assets
- -
- -
- -
- -
- -
- -
- -
- -
+ Disp of Intangible Assets
- -
- -
- -
- -
- -
- -
- -
- -
+ Acq of Fixed & Intang
- -
- -
- -
-1
-8
-1
-1
- -
+ Acq of Fixed Prod Assets
- -
- -
- -
-1
-8
-1
-1
- -
+ Acq of Intangible Assets
- -
- -
- -
- -
- -
- -
- -
- -
+ Cash (Repurchase) of Equity
- -
- -
223
- -
- -
35
- -
- -
+ Increase in Capital Stock
- -
- -
223
- -
- -
35
- -
- -
+ Decrease in Capital Stock
- -
- -
- -
- -
- -
- -
- -
- -
+ Net Change in LT Investment
22
3
28
-142
7
-50
54
70
+ Dec in LT Investment
71
47
43
115
236
171
202
158
+ Inc in LT Investment
-49
-43
-15
-257
-229
-221
-148
-88
+ Net Cash From Acq & Div
- -
- -
- -
- -
- -
- -
- -
- -
+ Cash from Divestitures
- -
- -
- -
- -
- -
- -
- -
- -
+ Cash for Acq of Subs
- -
- -
- -
- -
- -
- -
- -
- -
+ Cash for JVs
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Investing Activities
- -
- -
- -
- -
- -
- -
- -
- -
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
- -
- -
Cash from Investing Activities
22
3
28
-144
-1
-51
53
70
+ Dividends Paid
- -
- -
- -
- -
- -
- -
- -
- -
+ Net Cash From Debt
- -
- -
- -
- -
- -
- -
- -
- -
+ Cash From Debt
- -
- -
- -
- -
- -
- -
- -
- -
+ Repayments of Debt
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Financing Activities
- -
62
70
2
1
- -
- -
1
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
- -
- -
Cash from Financing Activities
- -
62
293
2
1
36
- -
1
Effect of Foreign Exchange Rates
- -
- -
- -
- -
- -
- -
- -
- -
Net Changes in Cash
7
43
288
-188
-64
-71
2
-3
EBITDA
-19
-26
-35
-58
-77
-79
-84
-86
EBITDA Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
Free Cash Flow
-16
-22
-33
-48
-72
-57
-52
-74
Net Cash Paid for Acquisitions
- -
- -
- -
- -
- -
- -
- -
- -
Free Cash Flow to Firm
- -
- -
- -
- -
- -
- -
- -
- -
Free Cash Flow to Equity
- -
-22
-33
-48
-72
-57
-52
-74
Free Cash Flow per Basic Share
-0.5
-0.71
-2.29
-1.06
-1.57
-1.18
-1.01
-1.4
Price/Free Cash Flow
- -
- -
-27.11
-23.06
-7.11
-2.72
-1.54
-0.89
Cash Flow to Net Income
0.87
0.87
0.95
0.81
0.87
0.81
0.87
0.95
Capital Expenditures
- -
- -
- -
-1
-8
-1
-1
- -